{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:01:27Z","timestamp":1788390087877,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jcms.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T18:47:59Z","timestamp":1553021279000},"page":"926-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society"],"prefix":"10.1016","volume":"47","author":[{"given":"Abdurrahman A.","family":"Al-Samman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand Sh.","family":"Al-Ani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2019.02.006_bib1","first-page":"1741","article-title":"Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treat-ment of 131 cases with ozone therapy","volume":"16","author":"Agrillo","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jcms.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1590\/S0004-27302010000200017","article-title":"Bisphosphonates in the treatment of metabolic bone diseases","volume":"54","author":"Arantes","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jcms.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.oraloncology.2009.01.002","article-title":"Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update","volume":"45","author":"Bagan","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1359\/jbmr.1999.14.9.1557","article-title":"A\u00a0dose-finding study of zoledronate in hypercalcemic cancer patients","volume":"14","author":"Body","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2019.02.006_bib5","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcms.2019.02.006_bib6","first-page":"1","article-title":"Radiographic findings in patients with medication-related osteonecrosis of the jaw","volume":"2017","author":"Cardoso","year":"2017","journal-title":"Int J Dent"},{"key":"10.1016\/j.jcms.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jcms.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-160X-7-7","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports","volume":"7","author":"Conte-Neto","year":"2011","journal-title":"Head Face Med"},{"key":"10.1016\/j.jcms.2019.02.006_bib9","series-title":"National study on avascular necrosis of the jaws","author":"Faculty of General Dental Practice","year":"2012"},{"key":"10.1016\/j.jcms.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","article-title":"Development of bisphosphonates","volume":"4","author":"Fleisch","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jcms.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and osteonecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jcms.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2019.02.006_bib13","first-page":"a930","article-title":"Denosumab-associated osteonecrosis of the jaw; a case series and literature review","volume":"9","author":"Kyriakidou","year":"2016","journal-title":"BJMP"},{"key":"10.1016\/j.jcms.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tripleo.2005.10.045","article-title":"Bisphosphonate-associated osteonecrosis of the jaws: report of a case and literature review","volume":"102","author":"Leite","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jcms.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/S0149-2918(03)80327-2","article-title":"Zoledronic acid: a new parenteral bisphosphonate","volume":"25","author":"Li","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcms.2019.02.006_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcms.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.14219\/jada.archive.2005.0110","article-title":"Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for pre-vention and early recognition","volume":"136","author":"Melo","year":"2005","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons. American association of oral and maxillofacial surgeons position paper on medication related osteonecrosis of the jaw - 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jcms.2019.02.006_bib22","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","article-title":"Osteonecro-sis of the jaw and the role of bisphosphonates: a critical review","volume":"122","author":"Silverman","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jcms.2019.02.006_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bdj.2017.79","article-title":"Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners","volume":"222","author":"Tanna","year":"2017","journal-title":"Br Dent J"},{"key":"10.1016\/j.jcms.2019.02.006_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1601-0825.2008.01494.x","article-title":"Dental panoramic radiographic evaluation in bisphosphonate associated osteonecrosis of the jaws","volume":"15","author":"Treister","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.jcms.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1503\/cmaj.050640","article-title":"Patients receiving intravenous bisphosphonates should avoid invasive dental procedures","volume":"172","author":"Wooltorton","year":"2005","journal-title":"CMAJ"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518218307546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518218307546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:41:10Z","timestamp":1760884870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518218307546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1010518218307546"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2019.02.006","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}